Evidence of Syntaxin 1A Involvement in Migraine Susceptibility
Open Access
- 1 April 2010
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 67 (4) , 422-427
Abstract
Migraine is a common neurological disorder, affecting about 15% of the general population.1,2 Familial aggregation studies have shown that migraine is essentially caused by genetic factors, with multiple genes contributing to its liability, in addition to environmental factors.3 We have also confirmed the presence of a genetic component in migraine with and without aura in a Portuguese population.4Keywords
This publication has 22 references indexed in Scilit:
- Familial Clustering of Migraine: Further Evidence From a Portuguese StudyHeadache: The Journal of Head and Face Pain, 2009
- The role of nitric oxide (NO) in migraine, tension-type headache and cluster headachePharmacology & Therapeutics, 2008
- Genetic and expression analyses reveal elevated expression of syntaxin 1A ( STX1A) in high functioning autismInternational Journal of Neuropsychopharmacology, 2008
- Migraine: a complex genetic disorderThe Lancet Neurology, 2007
- The search for migraine genes: an overview of current knowledgeCellular and Molecular Life Sciences, 2006
- Age-dependent prevalence and clinical features of migraineNeurology, 2006
- Epidemiology of headache in EuropeEuropean Journal of Neurology, 2006
- Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trialsThe Lancet, 2001
- Interactions between presynaptic Ca2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complexTrends in Pharmacological Sciences, 2001
- Nitric Oxide Modulates Synaptic Vesicle Docking/Fusion ReactionsNeuron, 1996